Breaking News
May 20, 2018 - Why drug users prefer heroin at home, but cocaine while out
May 20, 2018 - Gene therapy that reverses blindness in dogs could also help treat humans
May 20, 2018 - Opioid-Related Payments Linked to Increase in Opioid Rx
May 20, 2018 - Phone apps push people to take their pills
May 20, 2018 - Backbreaking Work May Shorten Men’s Lives
May 20, 2018 - Harsher drug laws won’t stop violence, argues former police chief
May 20, 2018 - Cognitive decline in dementia is not reduced by exercise
May 20, 2018 - Detecting breast cancer with non-invasive ‘disease screening pill’
May 20, 2018 - Simple treatment may minimize hearing loss triggered by loud noises
May 20, 2018 - Alignment of mother and offspring body clock could prevent diseases such as heart disease and obesity
May 20, 2018 - New commercial data warehouse for life sciences
May 20, 2018 - Practice Intervention Targeting IV Opioids May Cut Exposure
May 20, 2018 - New study provides insight into blood signatures of inflammation
May 20, 2018 - Scientists make breakthrough discovery about vitamin B12
May 20, 2018 - What Causes Cancer? Misconceptions Abound
May 20, 2018 - Proper burial of dead cells limits inflammation
May 20, 2018 - Study offers novel solution to suppress metastatic spread of deadly breast cancer
May 20, 2018 - Perspectives of patients and caregivers on care transitions
May 20, 2018 - Guidelines for weight gain in pregnancy should be changed for underweight and very obese women
May 20, 2018 - Researchers transplant retinal sheets derived from human embryonic stem cells in retinal degeneration mouse models
May 20, 2018 - U.S. military personnel at greater risk for skin cancer than general population
May 20, 2018 - Your immune system holds the line against repeat invaders, thanks to this molecule
May 20, 2018 - Between death and deportation
May 20, 2018 - Developing a High Throughput Mass Spectrometry Platform for Drug Discovery
May 19, 2018 - New project aims to increase awareness among hospital clinicians of non-beneficial treatment at end-of-life
May 19, 2018 - Automated bone scan index offers accurate, speedy prognostic information about prostate cancer
May 19, 2018 - Rutgers Cancer Institute nurses research various topics to enhance patient experience
May 19, 2018 - Computer models provide valuable insight to structure and function of Ebola, Zika viruses
May 19, 2018 - Study exposes key tactic used by deadly fungus
May 19, 2018 - Bacterial signals are crucial to development of pre-leukemic myeloproliferation, study shows
May 19, 2018 - Global experts identify key issues in supporting children with brain injuries transition back to school
May 19, 2018 - Social connections may protect black men who have sex with men from acquiring HIV
May 19, 2018 - Study IDs Factors Linked to Quality of Life With Dementia
May 19, 2018 - Potassium — Consumer
May 19, 2018 - HIV-1 viruses transmitted at birth are resistant to antibodies in mother’s blood
May 19, 2018 - Some water pitchers are much better at removing toxins, shows research
May 19, 2018 - Scientists discover how unusually long strands of RNA help colon cancer cells avoid death
May 19, 2018 - International study finds viable treatment option for people with mild asthma
May 19, 2018 - Mayo discovery could enable development of personalized ovarian, brain cancer treatments
May 19, 2018 - ‘Superbug’ Surfaces at Poultry Farm in China
May 19, 2018 - UCLA-designed program helps former HIV-positive inmates maintain health after release from jail
May 19, 2018 - New blood test could help avoid more than 40% of prostate biopsies, study finds
May 19, 2018 - Macrophages play key role in maintaining stem cell niche of mammary gland
May 19, 2018 - Ferritin Blood Test: MedlinePlus Lab Test Information
May 19, 2018 - Prolonged exposure to air pollution leads to genetic changes in rat brains, study finds
May 19, 2018 - Scientists identify new potential target to combat acute myeloid leukemia
May 19, 2018 - Ovarian cancer therapy may help treat patients with aggressive pancreatic cancer
May 19, 2018 - MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma
May 19, 2018 - Research shows that sexual activity and emotional closeness are unrelated to the rate of cognitive decline
May 19, 2018 - Nuffield Council on Bioethics outlines ethical issues arising from use of AI in healthcare
May 19, 2018 - Pancreatic cancer patients with BRCA1 or BRCA2 mutations fare better on platinum-based chemotherapy
May 19, 2018 - Tradeshow Talks with nal von minden Ltd
May 19, 2018 - Chemist begins new project to develop carbohydrate mimics to assist cancer therapies
May 19, 2018 - Healthy Lifestyle for Healthy Older Adults
May 19, 2018 - Epstein-Barr virus linked to seven serious diseases
May 19, 2018 - Biochemists isolate protein supercomplex from bacteria that generates voltage
May 19, 2018 - Mindfulness-based Stress Management Course for cancer survivors
May 19, 2018 - Simple screening tool can help identify people at increased risk for dementia
May 19, 2018 - Many gay and bisexual teenage boys use adult hookup apps to connect with friends, partners
May 19, 2018 - Maternal Exposure to Polluted Air Tied to Elevated Child BP
May 19, 2018 - Experimental drug extends survival in progeria
May 19, 2018 - FutureNeuro and GreenLight Medicines team up to develop cannabis-based treatments for epilepsies
May 19, 2018 - Brazilians with less education more likely to perceive as being in poor health
May 19, 2018 - Experts available to discuss subjects related to Ebola virus
May 19, 2018 - Opioid Makers’ Perks to Docs Tied to More Prescriptions
May 19, 2018 - AI detects patterns of gut microbes for cholera risk
May 19, 2018 - Researcher develops small molecules that inhibit derailment of gene expression in cancer
May 19, 2018 - Study brings fresh insights into biology of malaria parasite
May 19, 2018 - Microglia may play key role in slowing progression of prion diseases, research suggests
May 19, 2018 - Safety program successfully reduces SSIs in patients undergoing colorectal operations
May 19, 2018 - Clinical study supports usual medical care plus chiropractic care for low back pain
May 19, 2018 - Vermont legislators pass a drug importation law. So what?
May 19, 2018 - Trump proposes cutting planned parenthood funds. What does that mean?
May 19, 2018 - Cognitive training intervention reduces gait freezing in Parkinson’s patients, study shows
May 19, 2018 - Clinical trial begins enrollment to test safety of experimental MERS treatments
May 19, 2018 - Scientists disrupt two enzymes to shrink cancer cells
May 19, 2018 - 3D simulation reveals beneficial impact of medically induced brain cooling
May 19, 2018 - Natural antioxidant bilirubin may provide cardiovascular benefits
May 19, 2018 - Lash Group introduces latest solution for electronic benefit verification
May 19, 2018 - New CRISPR/Cas9 system targets regulatory genes of AIDS virus
Prazosin No Help for Improving Sleep in Vets with PTSD

Prazosin No Help for Improving Sleep in Vets with PTSD

image_pdfDownload PDFimage_print

Action Points

  • Note that this randomized trial found no benefit to prazosin in terms of sleep quality among veterans with PTSD.
  • As expected, the treatment group had more side effects such as dizziness and urinary incontinence.

Prazosin was not effective at treating post-traumatic stress disorder (PTSD)-related sleep issues among military veterans, a new trial reported.

The alpha-1-adrenoreceptor antagonist failed to achieve any of the three primary endpoints of the trial, with no significant changes in PTSD symptoms after 10 weeks compared with placebo, according to Murray A. Raskind, MD, of the Veterans Affairs Puget Sound Health Care System in Seattle, and colleagues.

According to the study, published in the New England Journal of Medicine, there were no major improvements seen in mean change from baseline for recurrent distressing dreams measured by the Clinical-Administered PTSD Scale (CAPS) item B2, sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI), or the Clinical Global Impression of Change score (CGIC):

  • CAPS: between-group difference 0.2 (95% CI, −0.3 to 0.8, P=0.38)
  • PSQI: 0.1 (−0.9 to 1.1, P=0.80)
  • CGIC: 0 (−0.3 to 0.3, P=0.96)

Similarly, the trial did not achieve secondary outcomes of improvement of these scores after 26 weeks of prazosin treatment.

“Trauma-related nightmares and sleep disturbance are common symptoms of PTSD. Enhanced central nervous system adrenergic activity and its persistence during sleep provide a rationale for the use of antiadrenergic medications to ameliorate these symptoms,” Raskind’s group explained, adding that of the α1-adrenergic antagonists available, prazosin “most readily enters the central nervous system.”

Recruited from 12 veterans affairs medical centers, 304 military veterans meeting the DSM-IV criteria for PTSD were included in the trial. All participants also had reported combat-related nightmares and a score of 50 or higher on the CAPS assessment. Those with low blood pressure or other medical illnesses were excluded.

Both groups were generally similar at baseline, with nearly all of the participants being male (96.1%; 99.3% placebo). Over a third of both groups reported having major depression at baseline (33.6%; 42.1%) and/or anxiety disorder besides PTSD (23.7%; 21.7%), and a majority of both groups were receiving a maintenance dose of an antidepressant at this time (78.3%; 77.0%).

Participants were randomized to receive either prazosin treatment (n=152) or placebo (n=152). Those receiving prazosin were administered an escalating dose for the initial 5 weeks of the trial, up to a maximum dose of 20 mg for men (5 mg mid-morning, 15 mg bedtime) or 12 mg for women (2 mg mid-morning, 10 mg bedtime).

Throughout the trial, use of psychotropic medications, including antidepressants, benzodiazepines, and non-opioid analgesics, was similar between the two groups.

After 10 weeks of treatment, those receiving prazosin reported a significant drop in both supine and standing blood pressures from baseline, which was not seen in the placebo group.

Light-headedness, dizziness, as well as urinary incontinence, were more commonly reported in the treatment group, although new or worsening suicidal thoughts were also less commonly reported among those on prazosin.

In an accompanying editorial, Kerry J. Ressler, MD, PhD, chief scientific officer and chief of the Division of Depression and Anxiety Disorders at McLean Hospital, a Harvard Medical School affiliate in Belmont, MA, called the findings both “surprising and disappointing.” He pointed out that the trial might have failed to replicate the findings of prior studies assessing prazosin possibly due to the exclusion of patients with social instability, those who were already on trazodone, and an inclusion of those with possible sleep apnea.

“Perhaps the most important lesson from this trial is a reminder that PTSD is a cluster of disorders that share trauma exposure as a cause but that can manifest with different combinations of symptoms,” Ressler continued, adding that “even though rational neuronal system-based therapy, including α1-adrenergic antagonism, may fit neatly with our current understanding of the disorder, only a subgroup of the millions of patients with PTSD may respond to an approach targeting α1-adrenergic receptors.”

Additional studies in this area should be more precisely targeted with “recognized biomarkers” as well as “intermediate phenotypes” to help isolate who is an ideal candidate for this type of treatment, he suggested.

The study was funded by the Department of Veterans Affairs Cooperative Studies Program.

Raskin and co-authors reported financial relationships with Merck, Tonix Pharmaceuticals, Jazz Pharmaceuticals, Actelion Pharmaceuticals, Neurocrine Biosciences, Pfizer, Braeburn Pharmaceuticals, Aptinyx, Janssen, Resilience Therapeutics, Oxeia Biopharmaceuticals, Laboratorio Farmaceutico CT, Lundbeck, PaxVax, PTC Therapeutics, and Boehringer Ingelheim.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-02-07T17:00:00-0500

Tagged with:

About author

Related Articles